Sector: MedicalVivus, Inc. (NASDAQ: VVUS)
Headlines
- Diabetes Care: Global Investing Opportunities
Nov 22, 2009 11:28 PM | ABT, ACCP, ALKS, AMLN, ASX, BDX
- PicksThatMove.com Announces Investment Opinion on Chicos FAS Inc., Petaquilla Minerals Ltd., Vivus Inc., iseemedia inc. and Power 3 Medical Products
Nov 18, 2009 01:13 PM | CHS, VVUS
- VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect Profile
Nov 18, 2009 06:30 AM | VVUS
- VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
Nov 17, 2009 04:01 PM | VVUS
- VIVUS to Present at Lazard Capital Markets Healthcare Conference
Nov 11, 2009 07:01 AM | VVUS
- VIVUS To Present at Merriman Curhan Ford's Investor Summit
Nov 05, 2009 07:03 AM | VVUS
- VIVUS Reports Third Quarter 2009 Highlights and Financial Results
Nov 03, 2009 04:01 PM | VVUS
- VIVUS Announces Promotion of Peter Tam to President
Nov 03, 2009 07:01 AM | VVUS
- Dr. Stockpick Announces Daily Stock Watch - VVUS, SHPGY, CNXT
Oct 30, 2009 12:40 PM | CNXT, VVUS
- Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
Oct 29, 2009 05:40 PM | VVUS
- 3 new diet pills race to hit market
Oct 22, 2009 01:15 PM | ARNA, VVUS
- Vivus Prices Public Offer at $10.50
Sep 18, 2009 09:52 AM | VVUS
- EBay, McDonald's, Capital 1, Apple big movers
Sep 09, 2009 05:52 PM | AAPL, ABX, BPOP, C, COF, EBAY
- PicksThatMove.Com Announces Investment Opinion on ARNA, MRVL, VVUS, NET and TSM
Oct 26, 2009 05:51 PM | ARNA, MRVL, TSM, VVUS
- VIVUS Reports Second Quarter 2009 Financial Results
Aug 11, 2009 04:00 PM | VVUS
- VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
Aug 04, 2009 08:01 AM | VVUS
- VIVUS Announces Date of Second Quarter 2009 Financial Results and Conference Call
Aug 03, 2009 08:02 AM | VVUS
- StockPreacher.com Issues Trading Outlook for Orexigen Therapeutics Inc.
Jul 24, 2009 06:50 AM | ARNA, ATHX, CYPB, OREX, VVUS
- VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes
Jun 08, 2009 06:00 PM | VVUS
- Weight Loss With Qnexa Stops Progression Toward Type 2 Diabetes in Obese Non-Diabetic Patients
Jun 07, 2009 12:00 AM | VVUS
- VIVUS to Present at the Needham and Company Life Sciences Conference
Jun 03, 2009 07:00 AM | VVUS
- Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
Jun 02, 2009 07:01 AM | VVUS
- VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
May 13, 2009 06:30 AM | VVUS
- Form 4 VIVUS INC For: Nov 05 Filed by: LOGAN MARK B (10K)
Nov 09, 2009 06:44 PM
- Form 3 Slebir John L For: Oct 30 (10K)
Nov 04, 2009 06:26 PM
- Form 4 VIVUS INC For: Oct 30 Filed by: TAM PETER Y (10K)
Nov 03, 2009 07:43 PM
- Form 4 VIVUS INC For: Sep 30 Filed by: MARSH GUY P (10K)
Oct 02, 2009 10:01 AM
- Form 4 VIVUS INC For: Sep 25 Filed by: MARSH GUY P (10K)
Sep 29, 2009 09:45 AM
- Form 4 VIVUS INC For: Sep 09 Filed by: MARSH GUY P (10K)
Sep 11, 2009 08:07 PM
- Form 4 WILSON LELAND F For: Sep 09 (10K)
Sep 11, 2009 08:00 PM
- Form 4 Perry Lee For: Sep 09 (10K)
Sep 11, 2009 08:00 PM
- Form 4 VIVUS INC For: Sep 11 Filed by: MARSH GUY P (10K)
Sep 11, 2009 08:00 PM
- Form 4 VIVUS INC For: Aug 31 Filed by: MARSH GUY P (10K)
Sep 02, 2009 06:58 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
VVUS
|
Compare to S&P
|
| YTD |
58.27 %
|
30.99 %
|
| 4 Weeks |
-8.28 %
|
-9.27 %
|
| 12 Weeks |
33.44 %
|
25.80 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -57.89 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -69.88 %
|
|
Sales Growth in Last Quarter: -82.59 %
|
|
